Biotech & Pharma
MATWIN highlights four innovative projects in the fight against cancer
Bordeaux, France, May 10, 2021 – MATWIN, the French oncology accelerator and subsidiary of Unicancer, today announces the four winners…
Biotech & Pharma
Clean Biologics SAS acquires Biodextris Inc.
Nantes, France, May 5, 2021 – Clean Biologics, a group providing services to the biopharmaceutical industry, today announces the acquisition…
Biotech & Pharma
Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody...
ALAMEDA, Calif. and TOULOUSE, France – May 4, 2021 – Exelixis, Inc. (Nasdaq: EXEL) and GamaMabs Pharma SA today announced that…
Medical Devices
Robocath successfully completes first robotic coronary angioplasties in Belgium
Rouen, France, May 4, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment…
Electronics, Photonics
Lynred accueille une visite de la députée de l’Isère et le sous-préfet à la relance
Grenoble, France, le 3 mai 2021 – Lynred, un leader mondial en développement et production de détecteurs infrarouges de haute…
Chemicals
NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
Strasbourg, France, April 22, 2021 – NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the appointment of Dr….
Chemicals
Minagro’s co-formulant in-can preservative, Sovinol P740/O, gains Ecocert certification
Louvain-la-Neuve, Belgium, April 20, 2021 – Minagro, a developer of high-quality green and safe products and solutions for the crop…
Medical Devices
Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces…
Biotech & Pharma
Tollys appoints Amina Zinaï, MD, as head of clinical development
Lyon, France, April 12, 2021 — Tollys, a biopharmaceutical company developing TL-532, the first synthetic specific agonist of Toll-like receptor…